| Tag | Content |
|---|
EnhancerAtlas ID | HS019-06688 |
Organism | Homo sapiens |
Tissue/cell | CD20+ |
Coordinate | chr17:7034820-7036950 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| HES2 | MA0616.2 | chr17:7035637-7035647 | GGCACGTGCC | + | 6.02 | | HES2 | MA0616.2 | chr17:7035637-7035647 | GGCACGTGCC | - | 6.02 | | IRF1 | MA0050.2 | chr17:7035779-7035800 | AAAAAAAAAAAGAAAGAAAGA | - | 6.25 | | IRF1 | MA0050.2 | chr17:7035813-7035834 | AAAGAAAAAGAGGAACTAAAA | - | 6.32 | | NR2C2 | MA0504.1 | chr17:7036015-7036030 | TGACCCCTGACCCCT | - | 7.2 | | Nr2f6(var.2) | MA0728.1 | chr17:7035063-7035078 | GAGGTCAGGAGTTCA | + | 6.22 | | SPI1 | MA0080.4 | chr17:7035817-7035831 | AAAAAGAGGAACTA | + | 6.66 |
|
| | Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
| SE_09336 | chr17:7032154-7043631 | CD14 | | SE_68171 | chr17:7013178-7041452 | TC32 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr17 | 7035816 | 7036492 | | chr17 | 7035868 | 7036444 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH17I007130 | chr17 | 7033542 | 7037519 |
|
Enhancer Sequence | TAGCCTGATT ACATTTTTTA AAGTCACCTT CAGGCTGCTG TATGAGGATG AACCTTTAGG 60
GGTGAGAGTT GGCAGGGGAT GTTGTTGCCA AAGTCCCAAA AGAGAGATGA CGATGGTGTT 120
TGGGACTGGA GGTGGCTGTG ACAACAGTGA GAAGATGTCA GATTAAAAGC AGATCATGTC 180
AGGGTGCGGT GGCTCACGCC TGTAACCCCA GCACTTTGGG AGGCTGAGGT GGGTGGATCC 240
TCTGAGGTCA GGAGTTCAAG ACCAGCCTGG CCAACATGGA GAAACCCCAT CTCTACTAAA 300
AATACAAAAA AAAAAAAAAA TTAGCTGGGC ATGGTGGCAG GCGCCTGTAA TCACAGCTAC 360
ACAGGAGGCT GAGGCAGGAG AATCGCTTGA ACCCGGGAGG CGGAGGTTGC AGTGAGCCAA 420
GATTGTACCA CTGCACTCCA GCCTGGGCGC CAAGAGCGAA GTCTCCGTCT CAAAAAACAA 480
AAGGGTAGAT AGTGAATCTT GGAGGAAGAA CCATCAACTC AGCACTGGCT GGGGAGGGCC 540
TGTGGGCGAG GAAAGGAAGG CTTCCTGAAG AAGCTTTGTA TGCTGCTGAG AAAGTGACAG 600
CAGGGTTAAC TGAGCGGGAA GAGGGGGCAG GAATGGGTTA AACGCGCAAT GTAGAAAGAG 660
GAACTGAAAG GGCCGGGCGC GGTGGGTCAT GCCTGTAATC CCGGCACTTT GGGAGGCCCA 720
GGGAGGCAGA TCACTTGAGG TCAGGAGTTC GAGACCAGCC TGGCCAACAT GGTGAAACTC 780
CATCTCTACT AAAAATATAA AATTAGCCGG GCGTGGTGGC ACGTGCCCGT AATCCCAGTT 840
ACTCGGGAGG CTGAGGCAGG AGAATCCCTT GAACCCAGGA GGCGGAGGTT GCAGTGAGCT 900
GAGATCACGT TATTGCACTC TAGCCTGGGC AACAAGAGCA AAACTCCATC TCAAAAAAAA 960
AAAAAAAAAA GAAAGAAAGA AAGAAAGAAA AGAAAAGAAA AAGAGGAACT AAAAAGAGCT 1020
CAATTTGGGA TAGACGGTGT TTGTGTTTGA GGTCCCTGTT AGACCCTAAG GTGAGATGCC 1080
AGGGCAGAAG CTGAATAAAC AATCCAGGCA GGAACACACA CTCACACACA TTGACCCCAA 1140
TCCCATGAGC CCCATTGTCC TGAAGACACA TCCCTGCTCC TGCCCAGCTG GTCCCTGACC 1200
CCTGACCCCT GGCTATGCTG GCCTCAGATC TGTGTCTCCT TCTCAAGTCA TTGGCCCCCA 1260
GGGCCACTGT CCCTCCGTCT CCACTGGGTG CACTGGAAAG GCAGGGTGAG GTACAAGAAG 1320
CCCCATTTAA AACCATGAAA TCAGCAGCTC AAACACCAGA AAGTCCCCAG CTTTTGCAAC 1380
AGCTCATAAG GACTGGTGTT TCCTGCGAGC AGTGACACCC TGCAGGTTTC TAAACTCTGC 1440
TTCTCTTTGT TTTGTAAAGC AGTGTTCTAT CAGTCCCGGA AAGCCCCTGG AGTGGATCAC 1500
GCCTCCCTAA TCTACCGTGT TCTGCATTTA TCTGCATCTG CAATGTTTGT TGTGGTCTTG 1560
TTGCTAGAGG CCTCGTTCCC CCTGCCTGGT TTATAAAATC CATGTAACCC AGGATTTTTT 1620
GTGGTGTGGA TACTCTACAT TGAAAGGACA TGCATGCTTT CTATTTTATT TATTTATTTA 1680
TTTATTATTT TTATTTTTAT TTTTATTTTT GGAGACGGAG TCTGGCTCTG TTGCCAGGCT 1740
GGAGTGCAGT GGCGCGATCT CGGCTCACTG CAACCTCCAC CTCCCAGGTT CAAGCGATTC 1800
TCCTGTCTCA GCCTCCCGAG TCGCTGGGAC TACAGGCGCT CGCCGCCACG CCTGGCTAAT 1860
TTTTTTTTTT TTTTTTTTTT TTTTTTTGTA TTTTAGTAGA GACGATGTTT CACCGTGTTG 1920
CCCAGGCTGG TCTCCAACTC CTGAGCTCAG GCAATCCGCC CGCCTTGGCC TCCCAAAGTG 1980
CTAGGATTAC AGGCGTGAGC CACCGTGCGC GGCCGACATG CATGCTTTTG AAATACCACA 2040
AGGGCACTGG GGACTGGAAA CAGGAACGGA AACAGGAAAG GTTCCCTTGT CCCCGTCGCA 2100
GGGCGTGTGA CAGCGGGAAT AGCTCGTTTT 2130
|
